About Anthony DePasqua
Form D filings for EnClear Therapies in 2024 list Anthony DePasqua as chief executive officer and director.
Anthony DePasqua first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony DePasqua in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anthony DePasqua works with at each company, as listed on that company's latest Form D.
EnClear Therapies, Inc. · Form D, Mar 1, 2024
